ProfileGDS4718 / 235153_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 60% 38% 51% 51% 76% 67% 58% 41% 52% 51% 44% 67% 76% 82% 52% 50% 82% 84% 96% 50% 58% 54% 47% 57% 83% 51% 68% 49% 75% 85% 69% 60% 48% 52% 62% 79% 58% 54% 50% 44% 79% 64% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4345649
GSM549102patient 115, normal, homogenized [OPG study]6.146960
GSM549104patient 119, normal, homogenized [OPG study]4.8948838
GSM549108patient 138, normal, homogenized [OPG study]5.6310451
GSM549119patient 077, normal, homogenized [OPG study]5.5612951
GSM549133patient 032, cancer, homogenized [OPG study]7.5919576
GSM549139patient 042, cancer, homogenized [OPG study]6.6279467
GSM549099patient 107, normal, homogenized [OPG study]5.9729158
GSM549109patient 139, normal, homogenized [OPG study]5.0533141
GSM549110patient 046, normal, homogenized [OPG study]5.6365452
GSM549114patient 063, normal, homogenized [OPG study]5.4915451
GSM549122patient 082, normal, homogenized [OPG study]5.1799244
GSM549134patient 033, cancer, homogenized [OPG study]6.6198367
GSM549136patient 036, cancer, homogenized [OPG study]7.4559576
GSM549140patient 044, cancer, homogenized [OPG study]8.1501382
GSM549111patient 047, normal, homogenized [OPG study]5.5934252
GSM549113patient 057, normal, homogenized [OPG study]5.4792950
GSM549132patient 031, cancer, homogenized [OPG study]8.0920482
GSM549137patient 038, cancer, homogenized [OPG study]8.3266784
GSM549142patient 047, cancer, homogenized [OPG study]9.8758996
GSM549100patient 110, normal, homogenized [OPG study]5.4972150
GSM549107patient 135, normal, homogenized [OPG study]5.9732758
GSM549115patient 068, normal, homogenized [OPG study]5.6849354
GSM549116patient 072, normal, homogenized [OPG study]5.3306947
GSM549120patient 078, normal, homogenized [OPG study]5.9460257
GSM549131patient 030, cancer, homogenized [OPG study]8.3121683
GSM549118patient 074, normal, homogenized [OPG study]5.5519651
GSM549129patient 027, cancer, homogenized [OPG study]6.7871468
GSM549123patient 088, normal, homogenized [OPG study]5.4243449
GSM549124patient 006, cancer, homogenized [OPG study]7.2616575
GSM549126patient 015, cancer, homogenized [OPG study]8.3957585
GSM549128patient 025, cancer, homogenized [OPG study]6.8454969
GSM549103patient 117, normal, homogenized [OPG study]6.1258760
GSM549117patient 073, normal, homogenized [OPG study]5.3725148
GSM549138patient 041, cancer, homogenized [OPG study]5.6156952
GSM549141patient 045, cancer, homogenized [OPG study]6.2965262
GSM549130patient 028, cancer, homogenized [OPG study]7.6968879
GSM549101patient 111, normal, homogenized [OPG study]6.0323858
GSM549105patient 128, normal, homogenized [OPG study]5.7836154
GSM549106patient 134, normal, homogenized [OPG study]5.467550
GSM549112patient 048, normal, homogenized [OPG study]5.1810544
GSM549125patient 011, cancer, homogenized [OPG study]7.654279
GSM549127patient 024, cancer, homogenized [OPG study]6.506664
GSM549135patient 035, cancer, homogenized [OPG study]7.0688671